Our website is made possible by displaying online advertisements to our visitors.
Please consider supporting us by disabling your ad blocker.
Omega Pharma
 | This article needs additional citations for verification. (July 2020) |
 | |
| Company type | Subsidiary company |
|---|---|
| ISIN | BE0003785020  |
| Industry | Pharmaceuticals |
| Founded | 1987 |
| Defunct | 2015 |
| Headquarters | Nazareth, Belgium |
Key people | Marc Coucke (Founder) |
| Products | Prescription-free medicines and healthcare products |
| Revenue | €1.27 billion (2014)[1] |
| €200 million (2014)[1] | |
| €69.5 million (2010)[2] | |
| Total assets | €1.443 billion (end 2010)[2] |
| Total equity | €718.3 million (end 2010)[2] |
Number of employees | 2,130 (end 2010)[2] |
| Parent | Perrigo Company plc |
| Website | omega-pharma |
Omega Pharma was a Belgian-based pharmaceutical company which was acquired in 2014 by Perrigo Company plc, an Irish/United States–based global pharmaceutical public company.[1][3] The company was founded in 1987 and was based in the Industrial area 'de Prijkels' in Nazareth.
- ^ a b c "Perrigo Company plc Completes Acquisition Of Omega Pharma Invest N.V., Creating A Top Five Global OTC Company". PR Newswire Association LLC. PR Newswire. 30 March 2015. Retrieved 1 July 2015.
- ^ a b c d "Annual Report 2010" (PDF). Omega Pharma. Archived from the original (PDF) on 23 March 2012. Retrieved 22 April 2011.
- ^ "Perrigo to buy Belgium's Omega Pharma for $3.11 billion". Thomson Reuters. Reuters. 6 November 2014.
Previous Page Next Page
